| Filed On | Filing |
|---|---|
| 04 Apr 2025 |
Form 3: Alloush Ramsey, Chief Operating Officer
Holds 507,674 shares of Common Stock, par value $0.0001 per share |
| 19 Jul 2024 |
Form 3: Pearce Michael Cooper, Director
No securities owned |
| 31 May 2024 |
Form 3: Fortress Biotech, Inc., 10% owner
Holds 4,110,467 shares of COMMON STOCK, PAR VALUE $0.0001 |
| 31 Jan 2023 |
Form 3: Benesch Joseph, Interim CFO
Holds 70,000 shares of Common Stock |
| 25 Jul 2022 |
Form 3: Rosenwald Lindsay A Md, Director
Holds 176,470 shares of Common Stock, par value $0.0001 per share |
| 26 Nov 2021 |
Form 3: Herskowitz Neil, Director
No securities owned |
| 26 Nov 2021 |
Form 3: Toledano Miranda Jayne, Director
No securities owned |
| 26 Nov 2021 |
Form 3: Smith Justin Adam, Director
No securities owned |
| 26 Nov 2021 |
Form 3: Paley Jeffrey, Director
No securities owned |
| 26 Nov 2021 |
Form 3: De Paolantonio Ernest Robert, Chief Financial Officer
No securities owned |
| 26 Nov 2021 |
Form 3: Maraoui Claude, Director
Holds 1,804,024 shares of COMMON STOCK |
Loading...